28329231|t|Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: a randomized controlled trial
28329231|a|Remote ischaemic preconditioning (RIPC) by inducing brief ischaemia in distant tissues protects the heart against myocardial ischaemia-reperfusion injury (IRI) in children undergoing open-heart surgery, although its effectiveness in adults with comorbidities is controversial. The effectiveness and mechanism of RIPC with respect to myocardial IRI in children with tetralogy of Fallot (ToF), a severe cyanotic congenital cardiac disease, undergoing open heart surgery are unclear. We hypothesized that RIPC can confer cardioprotection in children undergoing ToF repair surgery. Overall, 112 ToF children undergoing radical open cardiac surgery using cardiopulmonary bypass (CPB) were randomized to either a RIPC group (n = 55) or a control group (n = 57). The RIPC protocol consisted of three cycles of 5-min lower limb occlusion and 5-min reperfusion using a cuff-inflator. Serum inflammatory cytokines and cardiac injury markers were measured before surgery and after CPB. Right ventricle outflow tract (RVOT) tissues were collected during the surgery to assess hypoxia-inducible factor (Hif)-1α and other signalling proteins. Cardiac mitochondrial injury was assessed by electron microscopy. The primary results showed that the length of stay in the intensive care unit (ICU) was longer in the control group than in the RIPC group (52.30 ± 13.43 h vs. 47.55 ± 10.34 h, respectively, P = 0.039). Patients in the control group needed longer post-operative ventilation time compared to the RIPC group (35.02 ± 6.56 h vs. 31.96 ± 6.60 h, respectively, P = 0.016). The levels of post-operative serum troponin-T at 12 and 18 h, CK-MB at 24 h, as well as the serum h-FABP levels at 6 h, after CPB were significantly lower, which was coincident with significantly higher protein expression of cardiac Hif-1α, p-Akt, p-STAT3, p-STAT5, and p-eNOS and less vacuolization of mitochondria in the RIPC group compared to the control group. In ToF children undergoing open heart surgery, RIPC attenuates myocardial IRI and improves the short-term prognosis.
28329231	0	7	Cardiac	T023	C0018787
28329231	8	26	protective effects	T033	C1545588
28329231	30	62	remote ischaemic preconditioning	T061	C0376466
28329231	66	74	children	T100	C0008059
28329231	86	120	tetralogy of fallot repair surgery	T061	C0397326
28329231	124	151	randomized controlled trial	T062	C0206035
28329231	152	184	Remote ischaemic preconditioning	T061	C0376466
28329231	186	190	RIPC	T061	C0376466
28329231	195	203	inducing	T169	C0205263
28329231	210	219	ischaemia	T046	C0022116
28329231	223	230	distant	T082	C0443203
28329231	231	238	tissues	T024	C0040300
28329231	239	247	protects	T033	C1545588
28329231	252	257	heart	T023	C0018787
28329231	258	265	against	T080	C0521124
28329231	266	276	myocardial	T024	C0027061
28329231	277	305	ischaemia-reperfusion injury	T037	C0035126
28329231	307	310	IRI	T037	C0035126
28329231	315	323	children	T100	C0008059
28329231	335	353	open-heart surgery	T061	C0189745
28329231	368	381	effectiveness	T080	C1280519
28329231	385	391	adults	T100	C0001675
28329231	397	410	comorbidities	T078	C0009488
28329231	433	446	effectiveness	T080	C1280519
28329231	451	460	mechanism	T169	C0441712
28329231	464	468	RIPC	T061	C0376466
28329231	485	495	myocardial	T024	C0027061
28329231	496	499	IRI	T037	C0035126
28329231	503	511	children	T100	C0008059
28329231	517	536	tetralogy of Fallot	T019	C0039685
28329231	538	541	ToF	T019	C0039685
28329231	546	552	severe	T080	C0205082
28329231	553	561	cyanotic	T169	C0332580
28329231	562	572	congenital	T080	C1744681
28329231	573	588	cardiac disease	T047	C0018799
28329231	601	619	open heart surgery	T061	C0189745
28329231	624	631	unclear	T033	C3845108
28329231	654	658	RIPC	T061	C0376466
28329231	670	686	cardioprotection	T169	C0205245
28329231	690	698	children	T100	C0008059
28329231	710	728	ToF repair surgery	T061	C0397326
28329231	743	746	ToF	T019	C0039685
28329231	747	755	children	T100	C0008059
28329231	767	774	radical	T080	C0439807
28329231	775	795	open cardiac surgery	T061	C0189745
28329231	796	801	using	T169	C1524063
28329231	802	824	cardiopulmonary bypass	T061	C0007202
28329231	826	829	CPB	T061	C0007202
28329231	836	846	randomized	T080	C0439605
28329231	859	863	RIPC	T061	C0376466
28329231	864	869	group	UnknownType	C0681860
28329231	884	897	control group	T096	C0009932
28329231	912	916	RIPC	T061	C0376466
28329231	917	925	protocol	T061	C0040808
28329231	926	935	consisted	T080	C0332529
28329231	961	981	lower limb occlusion	T061	C0190956
28329231	992	1003	reperfusion	T061	C0027054
28329231	1012	1025	cuff-inflator	T074	C3881496
28329231	1027	1032	Serum	T031	C0229671
28329231	1033	1045	inflammatory	T169	C0333348
28329231	1046	1055	cytokines	T116,T129	C0079189
28329231	1060	1074	cardiac injury	T037	C0018805
28329231	1075	1082	markers	T201	C0005516
28329231	1088	1096	measured	T080	C0444706
28329231	1097	1103	before	T079	C0332152
28329231	1104	1111	surgery	T061	C0543467
28329231	1116	1121	after	T079	C0687676
28329231	1122	1125	CPB	T061	C0007202
28329231	1127	1156	Right ventricle outflow tract	T030	C0225892
28329231	1158	1162	RVOT	T030	C0225892
28329231	1164	1171	tissues	T024	C0040300
28329231	1177	1186	collected	T169	C1516698
28329231	1187	1193	during	T079	C0347984
28329231	1198	1205	surgery	T061	C0543467
28329231	1216	1249	hypoxia-inducible factor (Hif)-1α	T116,T123	C0965644
28329231	1254	1259	other	T080	C0205394
28329231	1260	1270	signalling	T038	C3537152
28329231	1271	1279	proteins	T116,T123	C0033684
28329231	1281	1288	Cardiac	T023	C0018787
28329231	1289	1302	mitochondrial	T026	C0026237
28329231	1326	1345	electron microscopy	T059	C0026019
28329231	1359	1366	results	T169	C1274040
28329231	1383	1397	length of stay	T079	C0023303
28329231	1405	1424	intensive care unit	T073,T093	C0021708
28329231	1426	1429	ICU	T073,T093	C0021708
28329231	1435	1441	longer	T080	C0205166
28329231	1449	1462	control group	T096	C0009932
28329231	1475	1479	RIPC	T061	C0376466
28329231	1480	1485	group	UnknownType	C0681860
28329231	1550	1558	Patients	T101	C0030705
28329231	1566	1579	control group	T096	C0009932
28329231	1587	1593	longer	T080	C0205166
28329231	1594	1608	post-operative	T079	C0032790
28329231	1609	1625	ventilation time	T033	C0456238
28329231	1626	1634	compared	T052	C1707455
28329231	1642	1646	RIPC	T061	C0376466
28329231	1647	1652	group	UnknownType	C0681860
28329231	1729	1743	post-operative	T079	C0032790
28329231	1744	1760	serum troponin-T	T034	C1318385
28329231	1777	1782	CK-MB	T059	C0523584
28329231	1807	1826	serum h-FABP levels	T034	C1254360
28329231	1841	1844	CPB	T061	C0007202
28329231	1850	1863	significantly	T078	C0750502
28329231	1864	1869	lower	T080	C0205251
28329231	1881	1891	coincident	T079	C0205420
28329231	1897	1910	significantly	T078	C0750502
28329231	1911	1917	higher	T080	C0205250
28329231	1918	1936	protein expression	T045	C1171362
28329231	1948	1954	Hif-1α	T116,T123	C0965644
28329231	1963	1970	p-STAT3	T116,T123	C1530116
28329231	1972	1979	p-STAT5	T116,T123	C1121634
28329231	1985	1991	p-eNOS	T116,T126	C0669365
28329231	1996	2000	less	T081	C0439092
28329231	2001	2014	vacuolization	T033	C0010840
28329231	2018	2030	mitochondria	T026	C0026237
28329231	2038	2042	RIPC	T061	C0376466
28329231	2043	2048	group	UnknownType	C0681860
28329231	2049	2057	compared	T052	C1707455
28329231	2065	2078	control group	T096	C0009932
28329231	2083	2086	ToF	T019	C0039685
28329231	2087	2095	children	T100	C0008059
28329231	2107	2125	open heart surgery	T061	C0189745
28329231	2127	2131	RIPC	T061	C0376466
28329231	2143	2153	myocardial	T024	C0027061
28329231	2154	2157	IRI	T037	C0035126
28329231	2162	2170	improves	T033	C0184511
28329231	2175	2185	short-term	T079	C0443303
28329231	2186	2195	prognosis	T201	C3854082